anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 58,861-58,890
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

58,861-58,890 of 110,355

filter-aware
65
The table provides a detailed breakdown of financial metrics for the International Rx segment, including non-GAAP profit measures.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
69
The slide contains two distinct tables for 2021 and 2020, detailing various expense adjustments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
71
The table reconciles GAAP to non-GAAP figures by adding back acquisition-related costs and adjustments.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
73
Contains two separate tables: one for annual periods (2017-2020) and one for quarterly periods (2020-2021).Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
81
The table reconciles GAAP operating cash flow to a non-GAAP adjusted figure by adding back legacy legal settlements, separation costs, and adjusting for Amoun operating activities.Bausch Health Companies | Results Presentation Deck | 90 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
08
The slide uses a structured layout to categorize achievements into three main pillars: COVID-19 vaccine, pipeline expansion, and corporate updates.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
09
Slide 9 of a BioNTech presentation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
13
The slide highlights BioNTech's global reach and commitment to equitable access.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Includes clinical trial data for BNT162b2 vs placebo.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Includes a dot plot for antibody titers, a sequence alignment table for T-cell epitopes, and a summary table for real-world effectiveness.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
20
The slide uses a hub-and-spoke style diagram to illustrate how different therapeutic modalities (mRNA, CAR-T, Antibodies, Small Molecules, Engineered Biologicals) contribute to two main strategic pillars: Targeting Cancer and Immunomodulation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
21
The slide uses a timeline-like visual representation for clinical phases.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
22
The slide uses a combination of a conceptual process diagram and flow cytometry data plots to validate the mechanism of action.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
23
The slide uses a combination of quantitative metrics and qualitative clinical context to establish the problem.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
24
Includes a citation to a Nature publication and a visual representation of the mRNA construct.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
26
The slide uses a geographic map to illustrate disease prevalence and a table to highlight low ORR and mOS for existing therapies.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
29
Clinical trial design diagram showing Part A (safety run-in) and Part B (randomization).BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
30
The diagram uses a process flow structure to show patient progression from surgery through screening to treatment allocation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
Includes a visual comparison of PK profiles (recombinant vs RiboCytokine) and a pipeline table for BNT151 and BNT152+153.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
32
Slide 32 of a presentation, likely BioNTech R&D day.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
35
The table shows a significant increase in commercial revenues and operating profit compared to the prior year.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
36
The chart uses a stacked bar format to decompose revenue into four categories, with a specific focus on COVID-19 vaccine revenue.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
37
The slide uses a structured layout with three distinct sections for revenue, expenses, and tax.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
39
The slide uses a hub-and-spoke diagram to categorize therapeutic modalities. Bottom text highlights a specific recent transaction (Kite).BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
41
Slide 41 from a BioNTech presentation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
10
Includes YoY growth percentages for each metric and detailed footnotes defining the metrics.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
11
PTG&A likely stands for Pre-opening, Technology, General & Administrative expenses.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The slide compares financial performance across five quarters (Q2'20 to Q2'21).Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
09
Includes Non-GAAP financial measures with a reference to disclosure slides.Broadridge Financial Solutions | Results Presentation Deck | 34 slides · Broadridge
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit